• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5054086)   Today's Articles (2540)
For: Goadsby PJ, Ailani J, Dodick DW, Starling AJ, Liu C, Liu Y, Yu SY, Smith JH, Brand-Schieber E, Trugman JM. Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial. Nat Med 2025:10.1038/s41591-025-03679-7. [PMID: 40355614 DOI: 10.1038/s41591-025-03679-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2024] [Accepted: 03/26/2025] [Indexed: 05/14/2025]
Number Cited by Other Article(s)
1
Schwaller F. Migraine drug is first to tackle debilitating early symptoms. Nature 2025;641:834. [PMID: 40355518 DOI: 10.1038/d41586-025-01503-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/14/2025]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA